Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

Molecular Oncology · Published 2026-07-28 · DOI 10.1002/1878-0261.70311

Free full text

Authors (8)

Ashlyn Conant, Nora Badiner, Sharon Asariah, Kiera McGivney, Vishwa Shah, Tise Suzuki, Yevgeniya J. Ioffe, Juli J. Unternaehrer

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Conant, A., Badiner, N., Asariah, S., et al. (2026). Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies. Molecular Oncology. https://doi.org/10.1002/1878-0261.70311

Related articles

• The X Factor in Immunity: Sex Differences Shaped by the X Chromosome · Immunological Reviews · 2026 · Cites or is cited by this article
• Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective · Molecular Oncology · 2026 · Same journal
• Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients · Molecular Oncology · 2026 · Same journal
• Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer · Molecular Oncology · 2026 · Same journal
• Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer · Molecular Oncology · 2026 · Same journal
• Translating whole‐genome doubling into precision medicine in cancer · Molecular Oncology · 2026 · Same journal
• Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr ‐mutated lung cancer · Molecular Oncology · 2026 · Same journal
• NKCC1 : A key regulator of glioblastoma progression · Molecular Oncology · 2026 · Same journal
• EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas · Molecular Oncology · 2026 · Same journal
• Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis · Molecular Oncology · 2026 · Same journal